New combo therapy could shorten hospital stays for severe colitis patients
NCT ID NCT07258771
First seen Jan 10, 2026 · Last updated May 11, 2026 · Updated 21 times
Summary
This study compares two treatments for people with a severe flare-up of ulcerative colitis, a condition causing intense diarrhea and bleeding. One group gets standard steroids alone, while the other gets steroids plus upadacitinib (Rinvoq), a pill that calms the immune system. The goal is to see if the combo works faster to control symptoms and avoid surgery or hospital readmission. About 110 adults will take part, and the results may help doctors choose the best treatment sequence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.